Plasmapheresis in Treatment of Fibrosing Cholestatic Hepatitis Due to Recurrent Hepatitis C after Liver Transplant

被引：0
|
作者：
Varma, Manish C. [1 ,2 ]
Tolkoff-Rubin, Nina [2 ,3 ]
Cosimi, A. Benedict [1 ,2 ]
Elias, Nahel [1 ,2 ]
Malik, Fahim [2 ,3 ]
Goes, Nelson B. [2 ,3 ]
Pratt, Daniel S. [2 ,4 ]
Thiim, Michael [2 ,4 ]
Andersson, Karin [2 ,4 ]
Markmann, James F. [1 ,2 ]
Hertl, Martin [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Surg, Div Transplant Surg, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Med, Div Renal, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [41] Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation
    Zylberberg, H
    Carnot, F
    Mamzer, MF
    Blancho, G
    Legendre, C
    Pol, S
    TRANSPLANTATION, 1997, 63 (01) : 158 - 160
  • [42] Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C including fibrosing cholestatic hepatitis following liver transplantation
    Strasser, S. I.
    Forns, X.
    Prieto, M.
    Charlton, M.
    Mchutchison, J. G.
    Symonds, W. T.
    Denning, J.
    Brandt-Sarif, T.
    Chang, P.
    Kivett, V.
    Baumert, T. F.
    Coilly, A.
    Castells, L.
    Habersetzer, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 92 - 92
  • [43] Sofosbuvir and Simeprevir for Treatment of Recurrent Hepatitis C Infection After Liver Transplant
    Nair, Satheesh
    Satapathy, Sanjaya K.
    Gonzalez, Humberto C.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (03) : 314 - 319
  • [44] Mechanism of action of ribavirin in treatment of recurrent hepatitis C after liver transplant
    Ouadri, R
    Giostra, E
    Rubbia-Brandt, L
    Mentha, G
    Malè, PJ
    Hadengue, A
    Negro, F
    JOURNAL OF HEPATOLOGY, 2000, 32 : 91 - 91
  • [45] Sofosbuvir Compassionate Use Program for Patients with Severe Recurrent Hepatitis C Including Fibrosing Cholestatic Hepatitis Following Liver Transplantation
    Forns, Xavier
    Prieto, Martin
    Charlton, Michael
    McHutchison, John G.
    Symonds, William T.
    Denning, Jill
    Brandt-Sarif, Theo
    Chang, Paul
    Kivett, Valerie
    Fontana, Robert J.
    Baumert, Thomas F.
    Coilly, Audrey
    Castells, Lluis
    Habersetzer, Francois
    LIVER TRANSPLANTATION, 2014, 20 : S150 - S150
  • [46] SOFOSBUVIR COMPASSIONATE USE PROGRAM FOR PATIENTS WITH SEVERE RECURRENT HEPATITIS C INCLUDING FIBROSING CHOLESTATIC HEPATITIS FOLLOWING LIVER TRANSPLANTATION
    Forns, X.
    Prieto, M.
    Charlton, M.
    McHutchison, J. G.
    Symonds, W. T.
    Denning, J.
    Brandt-Sarif, T.
    Chang, P.
    Kivett, V.
    Fontana, R. J.
    Baumert, T. F.
    Coilly, A.
    Castells, L.
    Habersetzer, F.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S26 - S26
  • [47] Response of fibrosing cholestatic recurrent hepatitis C following liver transplantation to combination interferon/ribavirin therapy
    Lilly, Les
    Deschenes, Marc
    Marotta, Paul J.
    HEPATOLOGY, 2007, 46 (04) : 479A - 480A
  • [48] Combination Therapy of Sofosbuvir and Simeprevir for Fibrosing Cholestatic Hepatitis C after Liver Transplantation.
    Lang, Melanie
    Polywka, Susanne
    Kluwe, Johannes
    Fischer, Lutz
    Jordan, Sabine
    Luetgehetmann, Mark
    Nashan, Bjoern
    Lohse, Ansgar
    Sterneck, Martina
    LIVER TRANSPLANTATION, 2014, 20 : S245 - S245
  • [49] SUCCESSFUL CONTROL OF FIBROSING CHOLESTATIC HEPATITIS C WITH SOFOSBUVIR IN A KIDNEY TRANSPLANT RECIPIENT
    Palmisano, Alessandra
    Degli Antoni, Anna Maria
    Vaglio, Augusto
    Piotti, Giovanni
    Cremaschi, Elena
    Buzio, Carlo
    Maggiore, Umberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 321 - 321
  • [50] Pathogenesis of recurrent hepatitis C virus-related progressive cholestatic hepatitis after liver transplantation
    GonzalezPeralta, RP
    Dickson, RC
    Lau, JYN
    HEPATOLOGY, 1997, 26 (04) : 1547 - 1547
12345